Man Group’s AbbVie ABBV Stock Holding History

Man Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.72M	Sell	35,500 -88,800	-71%	-$19.7M	0.01%	931
2025 Q4	$28.4M	Buy	124,300 +47,000	+61%	+$10.7M	0.05%	377
2025 Q3	$17.9M	Buy	77,300 +37,200	+93%	+$7.58M	0.03%	548
2025 Q2	$7.44M	Sell	40,100 -85,000	-68%	-$15.8M	0.01%	890
2025 Q1	$26.2M	Sell	125,100 -9,800	-7%	-$1.91M	0.07%	339
2024 Q4	$24M	Buy	134,900 +53,600	+66%	+$9.85M	0.06%	364
2024 Q3	$16.1M	Buy	81,300 +36,300	+81%	+$6.77M	0.04%	529
2024 Q2	$7.72M	Buy	45,000 +9,400	+26%	+$1.56M	0.02%	824
2024 Q1	$6.48M	Sell	35,600 -3,600	-9%	-$620K	0.02%	882
2023 Q4	$6.07M	Buy	+39,200	New	+$5.71M	0.02%	867
2023 Q3	–	Sell	-1,100	Closed	-$148K	–	1896
2023 Q2	$148K	Buy	+1,100	New	+$161K	﹤0.01%	1851
2023 Q1	–	Hold	0	–	–	–	2040

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Man Group's ABBV Position: Q1 2026 in Review

Man Group reduced its AbbVie (ABBV) stake by 1.9% in Q1 2026, selling an estimated $7.61M and leaving 1,774,415 shares worth $386M. The position accounts for 0.7% of the portfolio, ranked #12.

Man Group first reported a position in ABBV in Q1 2018 and has held it in 30 quarters since. The position peaked at $413M in Q4 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Man Group held 1,774,415 shares of AbbVie worth $386M as of Q1 2026.
Man Group sold 34,292 AbbVie shares in Q1 2026, an estimated $7.61M.
AbbVie made up 0.7% of Man Group's portfolio in Q1 2026, its #12 holding.
Man Group first reported a position in AbbVie in Q1 2018 and has held it in 30 quarters since.
Man Group's AbbVie position peaked at $413M in Q4 2025.
4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.